Eloxatin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors
Conditions:   Hepatocellular Carcinoma;   Lenvatinib;   Tislelizumab;   TACE;   Pharmorubicin;   Oxaliplatin Interventions:   Procedure: TACE;   Drug: Tislelizumab, Lenvatinib Sponsor:   Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials

Exercise and Oxaliplatin-induced Peripheral Neuropathy
Condition:   Peripheral Neuropathy Intervention:   Other: Aerobic Exercise Sponsor:   Dartmouth-Hitchcock Medical Center Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials